Penumbra Inc PEN

US Health Care

$321.19 ▲ +0.43% (+$1.36)

⬆️ Above Yest. High 📅 Earnings This Week

Open $323.05

Prev Close $319.83

Day Range $318.70 – $323.05

52W Range $221.26 – $362.41

Market Cap $12.63B

P/E (TTM) 73.78

Beta 0.70

EPS (TTM) $4.35

📋 Company Profile

Industry	Health Care
Country	US
Exchange	NEW YORK STOCK EXCHANGE, INC.
Currency	USD
IPO Date	2015-09-18
Shares Out.	39,330,000
Website	penumbrainc.com/ ↗
Phone	13025310855
Employees	4,700
Revenue	$374.8M
Gross Profit	$253.4M
Net Income	$32.6M
Free Cash Flow	$212.7M
Total Assets	$1.90B
Total Liabilities	$424.6M
Equity	$1.47B

About Penumbra Inc

Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.

Penumbra Inc is a publicly traded company under the ticker symbol PEN on the NEW YORK STOCK EXCHANGE, INC., operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.